Page last updated: 2024-10-31

midazolam and Ecchymosis

midazolam has been researched along with Ecchymosis in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Ecchymosis: Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leclère, FM1
Trelles, M1
Moreno-Moraga, J1
Servell, P1
Unglaub, F1
Mordon, SR1

Other Studies

1 other study available for midazolam and Ecchymosis

ArticleYear
980-nm laser lipolysis (LAL): About 674 procedures in 359 patients.
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2012, Volume: 14, Issue:2

    Topics: Adipose Tissue; Adult; Anesthesia, Local; Conscious Sedation; Ecchymosis; Esthetics; Female; Humans;

2012